Skip to search.
 TSX Up 0.51% TSX Ventures Up 1.80%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
0.45 Down 0.00(0.53%) 4:00PM EDT
Prev Close:0.45
Open:0.46
Bid:0.44 x 10200
Ask:0.45 x 8300
1y Target Est:1.92
Beta:0.648243
Earnings Date:May 6 - May 9 (Est.)
Day's Range:0.44 - 0.47
52wk Range:0.25 - 2.46
Volume:660,065
Avg Vol (3m):2,124,850
Market Cap:125.76M
P/E (ttm):N/A
EPS (ttm):-0.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CTICDown 0.53%125.76M
BMYUp 0.10%118.89B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.32
Quarterly EPS Est (Mar-16) :-0.04
Mean Recommendation*:3.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback